// App-Quantinova.ai

3741 : Antimetastatic activity of ISTH0047, a potent and selective TGF-beta 2 antisense oligonucleotide, in syngeneic lung metastatic model of mouse 4T1 mammary carcinoma

Researchers

Presenter

  • Katja Wosikowski

Principal Investigators

  • Kathy Hasenbach

  • Jutta Petschenka

  • Diana Barea Roldan

  • Sebastian Kreiter

  • Ugur Sahin

  • Guillaume Serin

  • Julie-Orlane Redon

  • Marc Hillairet de Boisferon

  • Francis Bichat

  • Hanna Kohonen

  • Michel Janicot

Medical Centers

  • Isarna Therapeutics, Munich, Germany

  • TRON, Mainz, Germany

  • Oncodesign, Dijon, France

Locations

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Mammary carcinoma

  • Lung Cancer

  • Solid malignancies

  • Twin-reversed arterial perfusion

Biomarkers

  • Programmed cell death protein 1

  • Cytotoxic T-lymphocyte-associated protein 4

  • Transforming growth factor beta

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved